Company: SXTPW
Filing Date: 2025-06-06
Form Type: DRS
Source: 0001213900-25-052232
Chunk: 5

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-06-06
Form: DRS
Chunk 5
---
, which may significantly reduce the amount of proceeds received
by us, and investors in this offering will not receive a refund in the event that we do not sell an amount of securities sufficient to
pursue our business goals described in this prospectus. In addition, because there is no escrow trust or similar arrangement and no minimum
offering amount, investors could be in a position where they have invested in our company, but we are unable to fulfill all of our contemplated
objectives due to a lack of interest in this offering. Further, any proceeds from the sale of securities offered by us will be available
for our immediate use, despite uncertainty about whether we would be able to use such funds to effectively implement our business plan.
We will bear all costs associated with the offering. See “Plan of Distribution” on page 35 of this prospectus for
more information regarding these arrangements

We intend to use the proceeds from this offering
for general corporate purposes, including working capital. See “Use of Proceeds.”

On February 24, 2025,
we effected a reverse stock split of our common stock at a ratio of 1-for-5. Unless otherwise indicated, all financial information,
share numbers, option numbers, warrant numbers, other derivative security numbers and exercise prices appearing in this registration statement
have been adjusted to give effect to the reverse stock split.

Investing in our securities involves a high degree of risk. See “ Risk Factors” beginning on page 18 of this prospectus for a discussion of information that should be considered in connection with an investment in our securities.

Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

We are an “emerging growth company” and a “smaller
reporting company” as defined in the Jumpstart Our Business Startups Act of 2012, and have elected to comply with certain reduced
public company reporting requirements.

|                                     |     | Per Share and 
 Accompanying  
 Warrants      |     | Per Pre- Funded 
 Warrant and     
 Accompanying    
 Warrants        |     | Total |
|:------------------------------------|:----|:--------------|:----|:----------------|:----|:------|
| Public offering price               |     | $             |     | $               |     | $     |
| Placement agent fees(1)             |     |